Heiko Bode

Deoxysphingolipids, Novel Biomarkers for Type 2 Diabetes, Are Cytotoxic for Insulin-Producing Cells

Richard A. Zuellig, Thorsten Hornemann, Alaa Othman et al. · Diabetes · 2013 · 129 citations · Full text

Insulin-producing Cells, Insulin Signaling, Irreversible Failure +19

HSAN1 mutations in serine palmitoyltransferase reveal a close structure–function–phenotype relationship

Heiko Bode, Florence Bourquin, Saranya Suriyanarayanan et al. · Human Molecular Genetics · 2015 · 88 citations · Full text

Peripheral Neuropathy, Biochemistry, Hsan1 Mutations +13

Elevation of plasma 1‐deoxy‐sphingolipids in type 2 diabetes mellitus: a susceptibility to neuropathy?

Maike F. Dohrn, Alaa Othman, Sarah Hirshman et al. · European Journal of Neurology · 2015 · 60 citations

Mutations at Ser331 in the HSN type I gene SPTLC1 are associated with a distinct syndromic phenotype

Michaela Auer‐Grumbach, Heiko Bode, Thomas R. Pieber et al. · European Journal of Medical Genetics · 2013 · 41 citations · Full text

Genetics, Molecular Biology, Pathology +19

Influence of light on ochratoxin biosynthesis by Penicillium

Markus Schmidt‐Heydt, Heiko Bode, Frank Raupp et al. · Mycotoxin Research · 2009 · 36 citations

Biosynthesis, Photochemistry, Biochemistry +5